The peer table above lists mutual funds with the same asset class and broad strategy as Rydex Biotechnology Inv (RYOIX). Compare expense ratio, AUM, and dividend yield to evaluate alternatives.
How does RYOIX compare to other mutual funds in its category?
Each peer row shows expense ratio and AUM alongside RYOIX so you can spot meaningful gaps — a 0.40% expense ratio vs a 0.06% peer is a real cost difference compounded over the long term. Click any peer to open its full analysis.
What is the expense ratio of RYOIX?
Rydex Biotechnology Inv (RYOIX) charges an expense ratio of 1.40%. This is the annual fee deducted from fund assets to cover management and operations.
